FDA Inspection 1122274 — Generics Bidco II LLC
The FDA completed an inspection of Generics Bidco II LLC on Mar 11, 2020 in Charlotte, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 11, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Charlotte, NC (United States)